Article
Engineered <em>Escherichia coli </em>Strains as Therapeutic Agents in Reactive Oxygen Species (ROS)-Mediated Glioblastoma Treatment: A Systematic Review of Mechanisms, Efficacy, and Challenges
2025-07-02
Abstract excerpt
Glioblastoma multiforme (GBM) remains one of the most aggressive and treatment-resistant brain tumors, characterized by a hostile microenvironment and poor prognosis. Recent advances in synthetic biology have led to the engineering of Escherichia coli (E. coli) strains as living therapeutics capable of targeting GBM via reactive oxygen species (ROS)-mediated mechanisms. This systematic review evaluates the mechani...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9371ca2d-0b22-591e-ab30-ae96d2d8c689
- DOI
- 10.20944/preprints202507.0181.v1
